Clinical Trials · NCT04666987
A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 359
- Start date
- Oct 2020
- Locations
- 28 sites, Italy
- Primary endpoint
- Change in Glycated Haemoglobin (HbA1c)